☰

Marian Novak, Ph.D. - Publications

Affiliations: 
2012 University of Kentucky, Lexington, KY 
Area:
Molecular Biology
Tree Info Grants Similar researchers PubMed Report error

32 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Leonard MK, Puts GS, Pamidimukkala N, Adhikary G, Xu Y, Kwok E, Jin Y, Snyder D, Matsangos N, Novak M, Mahurkar A, Shetty AC, Slominski RM, De Fabo EC, Noonan FP, et al. Correction: Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients. Oncogene. PMID 34635800 DOI: 10.1038/s41388-021-02045-4  0.631
2021 Lecker LS, Berlato C, Maniati E, Delaine-Smith R, Pearce OMT, Heath O, Nichols SJ, Trevisan C, Novak M, McDermott J, Brenton JD, Cutillas PR, Rajeeve V, Hennino A, Drapkin R, et al. TGFBI production by macrophages contributes to an immunosuppressive microenvironment in ovarian cancer. Cancer Research. PMID 34561272 DOI: 10.1158/0008-5472.CAN-21-0536  0.332
2021 Leonard MK, Puts GS, Pamidimukkala N, Adhikary G, Xu Y, Kwok E, Jin Y, Snyder D, Matsangos N, Novak M, Mahurkar A, Shetty AC, Slominski RM, De Fabo EC, Noonan FP, et al. Comprehensive molecular profiling of UV-induced metastatic melanoma in Nme1/Nme2-deficient mice reveals novel markers of survival in human patients. Oncogene. PMID 34433909 DOI: 10.1038/s41388-021-01998-w  0.678
2018 Hooda J, Novak M, Salomon MP, Matsuba C, Ramos RI, MacDuffie E, Song M, Hirsch MS, Lester J, Parkash V, Karlan BY, Oren M, Hoon DS, Drapkin R. Early loss of Histone H2B monoubiquitylation alters chromatin accessibility and activates key immune pathways that facilitate progression of ovarian cancer. Cancer Research. PMID 30563893 DOI: 10.1158/0008-5472.Can-18-2297  0.399
2018 Leonard MK, Novak M, Snyder D, Snow G, Pamidimukkala N, McCorkle JR, Yang XH, Kaetzel DM. The metastasis suppressor NME1 inhibits melanoma cell motility via direct transcriptional induction of the integrin beta-3 gene. Experimental Cell Research. PMID 30458180 DOI: 10.1016/J.Yexcr.2018.11.010  0.715
2018 Georgiadis A, Wood D, Murphy D, Parpart-Li S, Riley D, Sengamalay N, Novak M, Jones S, Angiuoli SA, Sausen M. Abstract 1286: Analytical validation of an integrated next-generation sequencing pan-cancer liquid biopsy approach for detection of microsatellite instability Cancer Research. 78: 1286-1286. DOI: 10.1158/1538-7445.Am2018-1286  0.341
2017 Labidi-Galy SI, Papp E, Hallberg D, Niknafs N, Adleff V, Noe M, Bhattacharya R, Novak M, Jones S, Phallen J, Hruban CA, Hirsch MS, Lin DI, Schwartz L, Maire CL, et al. High grade serous ovarian carcinomas originate in the fallopian tube. Nature Communications. 8: 1093. PMID 29061967 DOI: 10.1038/S41467-017-00962-1  0.335
2017 Leonard MK, McCorkle JR, Snyder DE, Novak M, Zhang Q, Shetty AC, Mahurkar AA, Kaetzel DM. Identification of a gene expression signature associated with the metastasis suppressor function of NME1: prognostic value in human melanoma. Laboratory Investigation; a Journal of Technical Methods and Pathology. PMID 29058705 DOI: 10.1038/Labinvest.2017.108  0.696
2017 Medrano M, Communal L, Brown KR, Iwanicki M, Normand J, Paterson J, Sircoulomb F, Krzyzanowski P, Novak M, Doodnauth SA, Saiz FS, Cullis J, Al-Awar R, Neel BG, McPherson J, et al. Interrogation of Functional Cell-Surface Markers Identifies CD151 Dependency in High-Grade Serous Ovarian Cancer. Cell Reports. 18: 2343-2358. PMID 28273451 DOI: 10.1016/J.Celrep.2017.02.028  0.406
2017 Hood J, Novak M, MacDuffie E, Lester J, Parkash V, Mills GB, Karlan BY, Oren M, Drapkin R. Abstract MIP-060: EPIGENETIC DYSREGULATION OF A HISTONE MARK REVEALS A METABOLIC VULNERABILITY IN OVARIAN CANCER Clinical Cancer Research. 23. DOI: 10.1158/1557-3265.Ovcasymp16-Mip-060  0.37
2017 Novak M, Angiuoli S, Diaz LA, Georgiadis A, Jones S, Loverso PR, Parpart-Li S, Sevdali M, Velculescu VE, Verner EL, White J, Zhang T, Sausen M. Abstract 604: Accurate identification and prioritization of candidate neoantigens from integrated cancer exome and transcriptome sequencing of FFPE samples Cancer Research. 77: 604-604. DOI: 10.1158/1538-7445.Am2017-604  0.324
2017 Leonard MK, Snow G, Novak M, McCorkle JR, Yang XH, Belkin A, Kaetzel DM. Abstract 4847: NME1 mediates a switch in beta integrin subunits that correlates with prolonged patient survival Cancer Research. 77: 4847-4847. DOI: 10.1158/1538-7445.Am2017-4847  0.596
2016 Liu JF, Palakurthi S, Zeng Q, Zhou S, Ivanova E, Huang W, Zervantonakis IK, Selfors LM, Shen Y, Pritchard CC, Zheng M, Adleff V, Papp E, Piao H, Novak M, et al. Establishment of patient-derived tumor xenograft models of epithelial ovarian cancer for pre-clinical evaluation of novel therapeutics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 27573169 DOI: 10.1158/1078-0432.Ccr-16-1237  0.321
2016 Iwanicki MP, Chen HY, Iavarone C, Zervantonakis IK, Muranen T, Novak M, Ince TA, Drapkin R, Brugge JS. Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. Jci Insight. 1. PMID 27482544 DOI: 10.1172/Jci.Insight.86829  0.389
2016 Iwanicki MP, Chen H, Zervantonakis I, Novak M, Muranen T, Ince TA, Drapkin R, Brugge JS. Abstract PR12: Mutant p53 drives early events in fallopian tube tumorigenesis through mesenchyme-associated autocrine production of matrix that supports survival and mesothelial intercalation. Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Ovca15-Pr12  0.423
2016 Agoston ES, Novak M, Salimi N, Chao A, Kent J, Agoston AT, Drapkin R. Abstract 4258: Multi-tumor cell culture medium supports a high take rate and improves culture growth rate in five tumor types Cancer Research. 76: 4258-4258. DOI: 10.1158/1538-7445.Am2016-4258  0.329
2015 Novak M, Leonard MK, Yang XH, Kowluru A, Belkin AM, Kaetzel DM. Metastasis suppressor NME1 regulates melanoma cell morphology, self-adhesion and motility via induction of fibronectin expression. Experimental Dermatology. 24: 455-61. PMID 25808322 DOI: 10.1111/Exd.12697  0.708
2015 Kaetzel DM, Leonard MK, Cook GS, Novak M, Jarrett SG, Yang X, Belkin AM. Dual functions of NME1 in suppression of cell motility and enhancement of genomic stability in melanoma. Naunyn-Schmiedeberg's Archives of Pharmacology. 388: 199-206. PMID 25017017 DOI: 10.1007/S00210-014-1010-4  0.701
2015 Leonard MK, Novak M, Yang X, Belkin A, Kaetzel D. Abstract 3257: NME1 mediates a switch in expression of beta integrin subunits that correlates with prolonged patient survival Cancer Research. 75: 3257-3257. DOI: 10.1158/1538-7445.Am2015-3257  0.703
2013 Jarrett SG, Novak M, Harris N, Merlino G, Slominski A, Kaetzel DM. NM23 deficiency promotes metastasis in a UV radiation-induced mouse model of human melanoma. Clinical & Experimental Metastasis. 30: 25-36. PMID 22699362 DOI: 10.1007/S10585-012-9495-Z  0.721
2013 Jarrett SG, Novak M, Cook GS, Kaetzel DM. Abstract C27: Potential contributions of genome-stabilizing activity of NM23 to its metastasis suppressor function in melanoma Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-C27  0.74
2013 Iwanicki MP, Novak M, Zervantonakis IK, Ince TA, Drapkin R, Brugge JS. Abstract A7: Targeting mutant p53 and cell-cell adhesion in ovarian cancer Clinical Cancer Research. 19. DOI: 10.1158/1078-0432.Ovca13-A7  0.387
2012 Deng X, Li Q, Hoff J, Novak M, Yang H, Jin H, Erfani SF, Sharma C, Zhou P, Rabinovitz I, Sonnenberg A, Yi Y, Zhou P, Stipp CS, Kaetzel DM, et al. Integrin-associated CD151 drives ErbB2-evoked mammary tumor onset and metastasis. Neoplasia (New York, N.Y.). 14: 678-89. PMID 22952421 DOI: 10.1593/Neo.12922  0.665
2012 Jarrett SG, Novak M, Dabernat S, Daniel JY, Mellon I, Zhang Q, Harris N, Ciesielski MJ, Fenstermaker RA, Kovacic D, Slominski A, Kaetzel DM. Metastasis suppressor NM23-H1 promotes repair of UV-induced DNA damage and suppresses UV-induced melanomagenesis. Cancer Research. 72: 133-43. PMID 22080566 DOI: 10.1158/0008-5472.Can-11-1795  0.706
2012 Ganguly SS, Fiore LS, Sims JT, Friend JW, Srinivasan D, Thacker MA, Cibull ML, Wang C, Novak M, Kaetzel DM, Plattner R. c-Abl and Arg are activated in human primary melanomas, promote melanoma cell invasion via distinct pathways, and drive metastatic progression. Oncogene. 31: 1804-16. PMID 21892207 DOI: 10.1038/Onc.2011.361  0.742
2012 Novak M, Yang XH, Jarrett SG, Kaetzel DM. Abstract 3435: NM23-H1 suppresses melanoma cell motility by promoting strong adhesions between fibronectin and α4α1 integrin Cancer Research. 72: 3435-3435. DOI: 10.1158/1538-7445.Am2012-3435  0.733
2012 Deng X, Hoff J, Novak M, Kaetzel D, Hemler ME, Yang XH. Abstract 2704: Tetraspanin CD151 drives mammary tumor onset and metastasis by coordinating integrin-dependent cell adhesion, motility, survival and signaling Cancer Research. 72: 2704-2704. DOI: 10.1158/1538-7445.Am2012-2704  0.68
2011 Novak M, Jarrett SG, McCorkle JR, Mellon I, Kaetzel DM. Multiple mechanisms underlie metastasis suppressor function of NM23-H1 in melanoma. Naunyn-Schmiedeberg's Archives of Pharmacology. 384: 433-8. PMID 21448569 DOI: 10.1007/S00210-011-0621-2  0.745
2011 Zhang Q, McCorkle JR, Novak M, Yang M, Kaetzel DM. Metastasis suppressor function of NM23-H1 requires its 3'-5' exonuclease activity. International Journal of Cancer. 128: 40-50. PMID 20209495 DOI: 10.1002/Ijc.25307  0.754
2011 Novak M, Kaetzel DM. Abstract 1455: Novel role for the metastasis suppressor NM23-H1 in suppression of transendothelial migration toward CXCL12 gradient Cancer Research. 71: 1455-1455. DOI: 10.1158/1538-7445.Am2011-1455  0.737
2011 Jarrett SG, Novak M, Harris N, Mellon I, Slominski A, Arnaud-Dabernat S, Daniel J, Kaetzel DM. Abstract 1445: The metastasis suppressor NM23-H1 promotes genomic stability through its 3’-5’ exonuclease and nucleoside diphosphate kinase activities following UV irradiation Cancer Research. 71: 1445-1445. DOI: 10.1158/1538-7445.Am2011-1445  0.723
2009 Kaetzel DM, McCorkle JR, Novak M, Yang M, Jarrett SG. Potential contributions of antimutator activity to the metastasis suppressor function of NM23-H1. Molecular and Cellular Biochemistry. 329: 161-5. PMID 19381784 DOI: 10.1007/S11010-009-0108-3  0.739
Show low-probability matches.